Newsroom

WASHINGTON--(BUSINESS WIRE)--A new research report commissioned by the District Department of Transportation reinforces what traffic expert Amy Witherite and other safety advocates have been warning: autonomous vehicles are not yet ready for unrestricted deployment in complex urban environments in complex urban environments, and a cautious, accountability-driven approach is essential. Amy Witherite, a leading advocate for roadway safety, highlighted the report’s findings as validation of ongoin...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Elite Express Holding Inc. (NASDAQ: ETS) resulting from allegations that Elite Express may have issued materially misleading business information to the investing public. So what: If you purchased Elite Express securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingenc...

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has been named a 2026 Top Workplace by USA TODAY. The award is based on employee feedback collected via a confidential survey measuring workplace experience and engagement. USA TODAY Top Workplaces recognizes midsize and large organizations in the US that are exceeding national benchmarks for employee satisfaction. “We are honored to be recognized with this national award, and proud to have created an environment that fosters ingenuity, insight and integr...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced clinical data indicating zocilurtatug pelitecan (zoci, formerly ZL-1310), a DLL3-targeting antibody-drug conjugate (ADC), provides rapid and robust intracranial responses in patients with previously treated extensive stage small cell lung cancer (ES-SCLC) and brain metastases as measured by independent assessment using modified Response Assessment in Neuro-Oncology for Brain Metastases (mRAN...

MARSEILLE--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que des résultats intermédiaires de l’étude de Phase 2 MATISSE évaluant IPH5201 en combinaison avec durvalumab et une chimiothérapie à base de platine dans le cancer du poumon non à petites cellules (CPNPC) opérable seront présentés lors d’une session plénière dédiée aux essais cliniques au congrès annuel de l’Association Américaine de la Recher...

KRAKÓW, Poland--(BUSINESS WIRE)--intoDNA announces that it will present two posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting....

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Soley Therapeutics Presents Preclinical Data Demonstrating Selective Anti-Tumor Activity of STX-6398, a First-in-Class CKAP2 Modulator, at AACR 2026...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akamis Bio, a clinical-stage oncology company working to advance the standard of care in colorectal cancer, today announced early data from the on-going Phase 1b FORTRESS study of NG-350A, an oncolytic immunotherapy for the treatment of mismatch repair-proficient (pMMR) locally advanced rectal cancer (LARC). NG-350A combined with chemoradiotherapy (CRT) demonstrated a composite response rate of 50 percent across the first 10 patients who completed the 12-week...

SAN DIEGO--(BUSINESS WIRE)--Onchilles at AACR26: New Preclinical Data from the Systemically Delivered NEU-002 Program Supports Advancement Toward Development Candidate Selection...

BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--Orum's New Preclinical Data at AACR 2026 on ORM-1153 Highlights Broad Activity in AML and the Potential for Improved Efficacy and Tolerability...